Nature medicine

Understanding how psychedelic medicines work

Updated

Abstract

Psychedelics may induce acute neural desynchronization and subacute neuroplasticity, leading to potential psychological and behavioral changes.

  • Classic psychedelics act on the serotonin 5-HT receptor to alter brain function and consciousness.
  • Preclinical and human studies suggest that psychedelics destabilize entrenched brain network patterns.
  • Evidence indicates that psychedelics may promote a period of neuroplasticity conducive to psychological change.
  • Therapeutic responses to psychedelics have been observed across various neuropsychiatric conditions.
  • Discrepancies exist between preclinical findings of non-hallucinogenic analogs and clinical evidence linking subjective experiences to therapeutic outcomes.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: J.S.S. is a consultant for Otsuka and Janssen and holds a provisional patent for the use of precision functional mapping for measuring target engagement by experimental therapeutics. C.L. has served as a scientific advisor to Delix Therapeutics and Brainify. G.E.N. has served as principal or co-investigator on studies funded by Alkermes, LB Pharmaceuticals, COMPASS Pathways, Usona Institute and Reunion Neuroscience. G.E.N. has served as a paid consultant for Carelon and Alkermes. R.L.C.-H. is a scientific advisor to TRYP therapeutics, MindSpace and Otsuka. M.P.B. has received research funding from Tilray Canada, Lykos Therapeutics, B.More, Ceruvia Life Sciences and Mind Medicine, serves on the Advisory Boards of Ajna Labs, Journey Colab and Bright Minds Biosciences, and provides consultation to Lilly USA and Otsuka Pharmaceutical Development & Commercialization.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free